Unlock instant, AI-driven research and patent intelligence for your innovation.

Preparation method of linezolid intermediate

A linezolid and body technology, which is applied in the field of preparation of linezolid intermediates, can solve the problems of high equipment requirements, cumbersome process, low yield and the like, and achieves easy industrial production, high reaction total yield and simple process. Effect

Active Publication Date: 2013-08-21
ZHEJIANG HISUN PHARMA CO LTD +1
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0019] The technical problem to be solved by the present invention is to overcome the harsh conditions, high requirements for equipment, certain potential safety hazards, low yield, difficult separation of by-products, high cost and technical problems in the existing linezolid preparation process. Complicated, not conducive to industrial production and other defects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of linezolid intermediate
  • Preparation method of linezolid intermediate
  • Preparation method of linezolid intermediate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] Example 1 (S)-2-((3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazoline)methyl)isoindole-1,3-dione Preparation of (I-1)

[0040]

[0041] Anhydrous lithium bromide (0.9g) and (S)-2-(oxirane-2-methylene)isoindole-1,3-dione (3.66g) were dissolved in N,N-dimethyl 3-Fluoro-4-morpholine phenyl isocyanate in DMF (4.0 g, 20 mL) was added to methyl formamide (DMF) (30 mL), and reacted at 60° C. for 4 h. 60 mL of water was added to the reaction liquid, filtered, the filter cake was washed with cold petroleum ether (10 mL×2), and dried to obtain 6.90 g of white solid, yield 90.11%.

[0042] ESI-MS (m / z): 426 (M+H), 448 (M+Na);

[0043] 1 HNMR (400MHz, CDCl 3 )δ: 3.04(m, 4H), 3.84(m, 4H), 3.95(m, 2H), 4.08(m, 2H), 4.95(m, 1H), 6.90(t, 1H), 7.1(m, 1H ), 7.37 (dd, 1H), 7.75 (m, 2H), 7.87 (m, 2H).

Embodiment 2

[0044] Example 2 (S)-2-((3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazoline)methyl)isoindole-1,3-dione preparation of

[0045] Anhydrous lithium bromide (0.9 g) and (S)-2-(oxirane-2-methylene)isoindole-1,3-dione (3.66 g) were dissolved in DMF (30 mL), respectively, A solution of 3-fluoro-4-morpholine phenylisocyanate in DMF (4.0 g, 20 mL) was added and reacted at 100° C. for 4 h. 60 mL of water was added to the reaction solution, filtered, the filter cake was washed with cold petroleum ether (10 mL×2), and dried to obtain 7.10 g of white solid, yield 92.72%.

[0046] ESI-MS (m / z): 426 (M+H), 448 (M+Na);

[0047] 1 HNMR (400MHz, CDCl 3 )δ: 3.04(m, 4H), 3.84(m, 4H), 3.95(m, 2H), 4.08(m, 2H), 4.95(m, 1H), 6.90(t, 1H), 7.1(m, 1H ), 7.37 (dd, 1H), 7.75 (m, 2H), 7.87 (m, 2H).

Embodiment 3

[0048] Example 3 (S)-2-((3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazoline)methyl)isoindole-1,3-dione preparation of

[0049] Anhydrous lithium bromide (0.9 g) and (S)-2-(oxirane-2-methylene)isoindole-1,3-dione (3.66 g) were dissolved in DMF (30 mL), respectively, A solution of 3-fluoro-4-morpholine phenylisocyanate in DMF (4.0 g, 20 mL) was added and reacted at 115° C. for 4 h. 60 mL of water was added to the reaction liquid, filtered, the filter cake was washed with cold petroleum ether (10 mL×2), and dried to obtain 7.29 g of white solid, yield 95.16%.

[0050] ESI-MS (m / z): 426 (M+H), 448 (M+Na);

[0051] 1 HNMR (400MHz, CDCl 3)δ: 3.04(m, 4H), 3.84(m, 4H), 3.95(m, 2H), 4.08(m, 2H), 4.95(m, 1H), 6.90(t, 1H), 7.1(m, 1H ), 7.37 (dd, 1H), 7.75 (m, 2H), 7.87 (m, 2H).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A new preparation method of a linezolid intermediate (S)-2-((3-(3-fluoro-4-morpholinephenyl)-2-oxo-5-oxazoline)methyl substituent (I) is characterized in that the intermediate (I) is obtained through cyclizing 3-fluoro-morpholinephenyl isocyanate (II) and an epoxy compound (III). The method has the advantages of short process route, low cost, simple operation, high yield, and suitableness for the industrialized production.

Description

technical field [0001] The present invention relates to a new process for the preparation of pharmaceutical intermediates, specifically the important intermediate (S)-2-((3-(3-fluoro-4-morpholinephenyl)- A new process for the synthesis of 2-oxo-5-oxazoline) methyl-substituted compound (I). Background technique [0002] Linezolid, the chemical name is (S)-N-{[3-(3-fluoro4-(4-morpholinyl-benzene)2-oxo-5-oxazoline]methyl}-B Amide, its structural formula is as shown in formula (IV) [0003] [0004] Linezolid is a new type of oxazolidinone antibacterial drug developed by Pharmacia&Upjohn (P&U). The drug acts on bacterial ribosomes and inhibits bacterial protein synthesis. It is mainly used for the treatment of bacteremia caused by vancomycin-resistant enterococci (VRE), pneumonia and comprehensive skin infections caused by methicillin-resistant Staphylococcus aureus (MRSA), and bacteremia caused by penicillin-resistant Streptococcus pneumoniae ( PRSP). [0005] (S)-2-((3...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D263/20C07D413/06
CPCC07D263/20C07D413/10C07D205/12C07D413/00C07D413/06C07D303/36C07D265/30C07D295/155
Inventor 张福利杨春波梁斌裘鹏程罗海荣李江柴健白骅蔡青峰
Owner ZHEJIANG HISUN PHARMA CO LTD
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More